Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.1K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.1K
Intellectual Disability01:29

Intellectual Disability

1.0K
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
1.0K
Dementia01:30

Dementia

672
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
672
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

812
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
812
Language and Cognition01:27

Language and Cognition

938
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
938

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.

Acta neuropathologica·2017
Same author

Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid: a clinico-imaging-pathological study of primary age-related tauopathy (PART).

Acta neuropathologica·2017
Same author

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition.

Alzheimer's & dementia (Amsterdam, Netherlands)·2017
Same author

Association Between Mentally Stimulating Activities in Late Life and the Outcome of Incident Mild Cognitive Impairment, With an Analysis of the APOE ε4 Genotype.

JAMA neurology·2017
Same author

Duration and Pathologic Correlates of Lewy Body Disease.

JAMA neurology·2017
Same author

<i>ABCA7</i> loss-of-function variants, expression, and neurologic disease risk.

Neurology. Genetics·2017
Same journal

Key Considerations in Telestroke Program Management.

Continuum (Minneapolis, Minn.)·2026
Same journal

Neurology's Action Potential: Delivering on the Promise of Brain Health.

Continuum (Minneapolis, Minn.)·2026
Same journal

Erratum.

Continuum (Minneapolis, Minn.)·2026
Same journal

Management of Large Artery Atherosclerosis.

Continuum (Minneapolis, Minn.)·2026
Same journal

Thrombolysis, Thrombectomy, and Antithrombotic Therapy for Acute Ischemic Stroke.

Continuum (Minneapolis, Minn.)·2026
Same journal

Stroke in Children and Younger Adults.

Continuum (Minneapolis, Minn.)·2026
See all related articles

Related Experiment Video

Updated: Mar 23, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

8.2K

Mild Cognitive Impairment.

Ronald C Petersen

    Continuum (Minneapolis, Minn.)
    |April 5, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Mild cognitive impairment (MCI) affects 15-20% of older adults and can progress to dementia. Early identification and understanding subtypes are crucial for potential treatment and patient counseling.

    More Related Videos

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    34.1K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Related Experiment Videos

    Last Updated: Mar 23, 2026

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
    12:18

    A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

    Published on: January 11, 2020

    8.2K
    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
    06:23

    The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

    Published on: October 13, 2016

    34.1K
    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
    07:42

    Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

    Published on: December 16, 2022

    3.9K

    Area of Science:

    • Gerontology
    • Neurology
    • Cognitive Science

    Background:

    • Cognitive function decline is a significant concern in aging populations.
    • Mild cognitive impairment (MCI) is a transitional state between normal aging and dementia.
    • Awareness of MCI is crucial for healthcare providers to manage patient care effectively.

    Purpose of the Study:

    • To review the evolving concept and clinical significance of mild cognitive impairment (MCI).
    • To highlight the prevalence, progression, and diagnostic challenges associated with MCI.
    • To emphasize the importance of identifying MCI subtypes for targeted interventions.

    Main Methods:

    • Review of international population-based studies on MCI prevalence.
    • Analysis of data on MCI progression rates to dementia.
    • Examination of emerging biomarkers for Alzheimer's disease in MCI patients.

    Main Results:

    • MCI prevalence is estimated at 15-20% in individuals aged 60 and above.
    • The annual progression rate of MCI to dementia ranges from 8% to 15%.
    • Biomarkers show promise in identifying Alzheimer's disease etiology and predicting progression in MCI.

    Conclusions:

    • MCI is a clinically significant condition requiring identification and appropriate management.
    • Understanding MCI diagnostic features is essential for effective patient counseling.
    • Ongoing research and clinical trials are vital for developing effective MCI treatments.